Literature DB >> 19075510

Establishment and characterization of mammalian cell lines stably expressing human L-type amino acid transporters.

Emiko Morimoto1, Yoshikatsu Kanai, Do Kyung Kim, Arthit Chairoungdua, Hye Won Choi, Michael F Wempe, Naohiko Anzai, Hitoshi Endou.   

Abstract

System L (SL), a basolateral amino acid transporter, transports large neutral amino acids (LNAAs) in a Na(+)-independent manner. Previously, we identified two isoforms of transporters: L-type amino acid transporter 1 (LAT1) and 2 (LAT2) and revealed their distinct substrate selectivity and transport properties. In this study, to establish more stable human LAT1 (hLAT1) and LAT2 (hLAT2) in vitro assay systems, we established mouse cell lines stably expressing hLAT1 (S2-LAT1) and hLAT2 (S2-LAT2). Real-time quantitative RT-PCR analysis revealed that S2-LAT1 and S2-LAT2 cells express hLAT1 and hLAT2 mRNAs at 20 - 1000-fold higher levels than those of endogenous mouse Lat1 and Lat2. S2-LAT1 and S2-LAT2 mediated [(14)C]L-leucine transport properties were measured and corresponded to results observed via Xenopus oocytes. Using these cells, the data demonstrate that hLAT1 and hLAT2 exhibit different characters in the acceptance of alpha-methyl amino acids and amino acid-related compounds with bulky side chains such as thyroid hormones and melphalan. S2-LAT1 and S2-LAT2 cells are expected to facilitate hLAT1 and hLAT2 substrate recognition research and contribute to drug development by providing an efficient assay system to screen for chemical compounds that interact with hLAT1 and hLAT2.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19075510     DOI: 10.1254/jphs.08232fp

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  20 in total

1.  Protein kinase C activation upregulates human L-type amino acid transporter 2 function.

Authors:  Hanae Morio; Yoshie Reien; Yuri Hirayama; Hirofumi Hashimoto; Naohiko Anzai
Journal:  J Physiol Sci       Date:  2021-03-31       Impact factor: 2.781

2.  Structural insights into thyroid hormone transport mechanisms of the L-type amino acid transporter 2.

Authors:  Katrin M Hinz; Katja Meyer; Anita Kinne; Ralf Schülein; Josef Köhrle; Gerd Krause
Journal:  Mol Endocrinol       Date:  2015-05-06

3.  HOXB9 acts as a negative regulator of activated human T cells in response to amino acid deficiency.

Authors:  Keitaro Hayashi; Motoshi Ouchi; Hitoshi Endou; Naohiko Anzai
Journal:  Immunol Cell Biol       Date:  2016-03-01       Impact factor: 5.126

Review 4.  Thyroid hormone transporters--functions and clinical implications.

Authors:  Juan Bernal; Ana Guadaño-Ferraz; Beatriz Morte
Journal:  Nat Rev Endocrinol       Date:  2015-05-05       Impact factor: 43.330

5.  Effect of α-Methyl versus α-Hydrogen Substitution on Brain Availability and Tumor Imaging Properties of Heptanoic [F-18]Fluoroalkyl Amino Acids for Positron Emission Tomography (PET).

Authors:  Ahlem Bouhlel; Wadha Alyami; Aixiao Li; Liya Yuan; Keith Rich; Jonathan McConathy
Journal:  J Med Chem       Date:  2016-03-23       Impact factor: 7.446

6.  Antagonists of the system L neutral amino acid transporter (LAT) promote endothelial adhesivity of human red blood cells.

Authors:  Laura Beth Mann Dosier; Vikram J Premkumar; Hongmei Zhu; Izzet Akosman; Michael F Wempe; Timothy J McMahon
Journal:  Thromb Haemost       Date:  2017-04-06       Impact factor: 5.249

7.  Involvement of the L-Type Amino Acid Transporter Lat2 in the Transport of 3,3'-Diiodothyronine across the Plasma Membrane.

Authors:  Anita Kinne; Melanie Wittner; Eva K Wirth; Katrin M Hinz; Ralf Schülein; Josef Köhrle; Gerd Krause
Journal:  Eur Thyroid J       Date:  2015-05-28

Review 8.  Tissue thyroid hormones and thyronamines.

Authors:  Alice Accorroni; Federica Saponaro; Riccardo Zucchi
Journal:  Heart Fail Rev       Date:  2016-07       Impact factor: 4.214

9.  The role of LAT1 in (18)F-DOPA uptake in malignant gliomas.

Authors:  Ryan S Youland; Gaspar J Kitange; Timothy E Peterson; Deanna H Pafundi; Judi A Ramiscal; Jenny L Pokorny; Caterina Giannini; Nadia N Laack; Ian F Parney; Val J Lowe; Debra H Brinkmann; Jann N Sarkaria
Journal:  J Neurooncol       Date:  2012-10-20       Impact factor: 4.130

10.  Biological significance of fluorine-18-α-methyltyrosine (FAMT) uptake on PET in patients with oesophageal cancer.

Authors:  S Suzuki; K Kaira; Y Ohshima; N S Ishioka; M Sohda; T Yokobori; T Miyazaki; N Oriuchi; H Tominaga; Y Kanai; N Tsukamoto; T Asao; Y Tsushima; T Higuchi; T Oyama; H Kuwano
Journal:  Br J Cancer       Date:  2014-03-25       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.